4//SEC Filing
GHALIE RICHARD G 4
Accession 0001567619-21-009092
CIK 0001262104other
Filed
May 4, 8:00 PM ET
Accepted
May 5, 4:02 PM ET
Size
13.4 KB
Accession
0001567619-21-009092
Insider Transaction Report
Form 4
MEI Pharma, Inc.MEIP
GHALIE RICHARD G
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-05-03+75,000→ 75,000 totalExercise: $3.55Exp: 2031-05-03→ Common Stock (75,000 underlying)
Holdings
- 650,000
Stock Option (Right to Buy)
Exercise: $3.49Exp: 2030-07-02→ Common Stock (150,000 underlying) - 220,000
Stock Option (Right to Buy)
Exercise: $2.88Exp: 2027-07-07→ Common Stock (65,000 underlying) - 350,000
Stock Option (Right to Buy)
Exercise: $4.28Exp: 2028-07-12→ Common Stock (130,000 underlying) - 500,000
Stock Option (Right to Buy)
Exercise: $2.52Exp: 2029-07-01→ Common Stock (150,000 underlying) - 130,000
Stock Option (Right to Buy)
Exercise: $1.21Exp: 2026-03-07→ Common Stock (130,000 underlying) - 155,000
Stock Option (Right to Buy)
Exercise: $1.38Exp: 2026-07-14→ Common Stock (25,000 underlying)
Footnotes (6)
- [F1]1/4th of shares vest one-year from 5/03/2021, with the remaining balance of shares vesting in 36 equal amounts over three years.
- [F2]All options are currently exercisable.
- [F3]1/4th of shares vest one-year from July 7, 2017, with the remaining balance of shares vesting in 36 equal amounts over three years.
- [F4]1/4th of shares vest one-year from July 12, 2018, with the remaining balance of shares vesting in 36 equal amounts over three years.
- [F5]1/4th of shares vest one-year from July 1, 2019, with the remaining balance of shares vesting in 36 equal amounts over three years.
- [F6]1/4th of shares vest one-year from July 2, 2020, with the remaining balance of shares vesting in 36 equal amounts over three years.
Documents
Issuer
MEI Pharma, Inc.
CIK 0001262104
Entity typeother
Related Parties
1- filerCIK 0001156208
Filing Metadata
- Form type
- 4
- Filed
- May 4, 8:00 PM ET
- Accepted
- May 5, 4:02 PM ET
- Size
- 13.4 KB